Antonella D'Arminio Monforte Selected Research

Antonella D'Arminio Monforte Research Topics

Disease

13	Acquired Immunodeficiency Syndrome (AIDS) 11/2020 - 01/2002
10	Infections 03/2024 - 10/2002
6	Disease Progression 10/2023 - 01/2002
6	Coinfection 12/2022 - 10/2002
5	COVID-19 02/2024 - 11/2020
3	Fibrosis (Cirrhosis) 12/2022 - 06/2011
3	Myocardial Infarction 07/2011 - 04/2008
2	Pneumonia (Pneumonitis) 10/2023 - 03/2023
2	Chronic Renal Insufficiency 12/2022 - 10/2019
2	Hepatitis C 12/2022 - 06/2014
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 09/2014
2	Inflammation (Inflammations) 06/2021 - 06/2021
2	Viremia 01/2017 - 08/2003
2	HIV Infections (HIV Infection) 01/2017 - 05/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2013 - 07/2011
2	Kaposi Sarcoma (Kaposi's Sarcoma) 12/2003 - 08/2003
1	Respiratory Insufficiency (Respiratory Failure) 10/2023
1	Fever (Fevers) 12/2022
1	Cytokine Release Syndrome 12/2022
1	Dyspnea (Shortness of Breath) 12/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Chronic Hepatitis C 01/2022
1	Cognitive Dysfunction 11/2021
1	Headache (Headaches) 11/2021
1	Confusion (Bewilderment) 11/2021
1	Overweight 06/2021
1	Hyperphosphatemia 11/2019
1	Stroke (Strokes) 08/2019
1	Lymphopenia (Lymphocytopenia) 06/2010
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2010
1	Diabetes Mellitus 01/2010
1	Coronary Disease (Coronary Heart Disease) 04/2008
1	Osteoporosis 08/2006
1	Neoplasms (Cancer) 08/2003

Drug/Important Bio-Agent (IBA)

9	RNA (Ribonucleic Acid)IBA 12/2022 - 01/2008
5	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2008
3	Anti-HIV Agents (AIDS Drugs)IBA 10/2019 - 01/2010
2	Antiviral Agents (Antivirals)IBA 12/2022 - 01/2022
2	C-Reactive ProteinIBA 06/2021 - 09/2013
2	Protease Inhibitors (Protease Inhibitor)IBA 10/2019 - 01/2010
2	HDL CholesterolIBA 09/2014 - 07/2011
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2013 - 01/2010
2	abacavir (Ziagen)FDA Link 11/2011 - 04/2008
2	Reverse Transcriptase InhibitorsIBA 04/2008 - 08/2006
2	NucleosidesIBA 04/2008 - 08/2006
1	DNA (Deoxyribonucleic Acid)IBA 03/2024
1	reparixinIBA 10/2023
1	Interleukin-8 (Interleukin 8)IBA 10/2023
1	sarilumabIBA 03/2023
1	Interleukin-6 InhibitorsIBA 03/2023
1	Growth Differentiation Factor 15IBA 12/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Oxygen (Dioxygen)IBA 11/2020
1	remdesivirIBA 11/2020
1	IronIBA 11/2019
1	Phosphates (Orthophosphate)IBA 11/2019
1	Ribavirin (Virazole)FDA LinkGeneric 01/2018
1	Tenofovir (Viread)FDA Link 01/2018
1	Integrase InhibitorsIBA 01/2018
1	Viral RNAIBA 01/2018
1	LDL CholesterolIBA 09/2014
1	Alkaline PhosphataseIBA 09/2014
1	Glucose (Dextrose)FDA LinkGeneric 09/2014
1	HDL LipoproteinsIBA 09/2014
1	LDL Lipoproteins (beta Lipoproteins)IBA 09/2014
1	EnzymesIBA 06/2014
1	Lopinavir FDA Link 11/2011
1	efavirenz (Sustiva)FDA Link 11/2011
1	Triglycerides (Triacylglycerol)IBA 07/2011
1	CholesterolIBA 07/2011
1	Atazanavir Sulfate (Reyataz)FDA Link 06/2011
1	Antihypertensive Agents (Antihypertensives)IBA 01/2010
1	LipidsIBA 01/2010
1	ThymidineIBA 01/2010
1	Zidovudine (Retrovir)FDA LinkGeneric 04/2008
1	Lamivudine (Epivir)FDA Link 04/2008
1	Stavudine (Zerit)FDA LinkGeneric 04/2008
1	Didanosine (Videx)FDA LinkGeneric 04/2008
1	Indicators and Reagents (Reagents)IBA 01/2008
1	insulin receptor-related receptor (IRR)IBA 01/2008
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2008
1	AzolesIBA 01/2008
1	Hemoglobins (Hemoglobin)IBA 01/2002

Therapy/Procedure

12	Highly Active Antiretroviral Therapy (HAART) 06/2021 - 01/2002
11	Therapeutics 10/2023 - 10/2002
1	Retention in Care 02/2024
1	Aftercare (After-Treatment) 12/2022
1	Art Therapy 01/2017